Clik here to view.
Enable Injections Appoints David Kroekel as Chief Operating Officer
– Promotion supports commitment to continued manufacturing and product development success for enFuse® platform – CINCINNATI, Feb. 7, 2024 /PRNewswire/ – Enable Injections, Inc. (“Enable”), a leading...
View ArticleEnable Injections Announces Plans to Expand Manufacturing Facilities and...
New state-of-the-art facility to be located in Springdale, Ohio Expansions will support ongoing clinical and commercial supply of Company’s enFuse technology CINCINNATI, Feb. 14, 2024 /PRNewswire/ –...
View ArticleClik here to view.
Greg Etter Joins Enable Injections as VP, Engineering and Automation
Greg-etter Greg Etter Joins Enable Injections as VP, Engineering and Automation We are pleased to announce Greg Etter has joined Enable Injections as the Vice President of Engineering and Automation....
View ArticleEnable Injections Expands Strategic Partnership with Roche
CINCINNATI, May 07, 2024 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a leading innovator in developing and manufacturing the enFuse® platform of wearable drug delivery device technology,...
View ArticleClik here to view.
Enable Injections and Serina Therapeutics Announce Agreement to Develop...
CINCINNATI and HUNTSVILLE, Alabama, May 15, 2024 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery...
View ArticleEnable Injections Names Matthew Huddleston as Chief Commercial Officer
Appointment supports Company’s pursuit of additional enFuse combination product approvals and commercial success CINCINNATI, May 22, 2024 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a...
View ArticleEnable Injections Announces Agreement with Sobi® to Develop and Distribute...
CINCINNATI, September 12, 2024 / – Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, and Swedish Orphan...
View ArticleAn Award-Winning Year: A Look Back at 2024
It’s been another pivotal year at Enable Injections, including several exciting announcements and awards to continue our momentum into 2025. As the year draws to a close, it’s easy to forget some of...
View ArticleEnable Injections Announces Regulatory CE Mark Approval in Europe for enFuse...
CINCINNATI, March 25, 2025 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, today...
View ArticleEnable Injections Presents Survey Results Highlighting Missed Opportunities...
CINCINNATI, April 25, 2025 (GLOBE NEWSWIRE) — Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform, announced...
View Article